<strong id="lryfd"><menu id="lryfd"><input id="lryfd"></input></menu></strong>
  • 国产亚洲精品??码,欧美另类潮喷,国产人妖网站,永久免费看mv亚洲,你懂的国产在线,久久AV秘?一区二区三区水生,欧美成人综合,久久AV高潮AV
    更新于 12月8日

    輝瑞制藥-China Strategy Consultant-上海

    5-8萬
    • 北京東城區
    • 5-10年
    • 本科
    • 全職
    • 招1人

    雇員點評標簽

    • 同事很nice
    • 團隊執行強
    • 工作環境好
    • 人際關系好
    • 氛圍活躍
    • 實力大公司

    職位描述

    藥企
    Brief Introduction of Pfizer China
    Pfizer began its operations in China in the 1980’s and has become the No. 1 pharmaceutical company in China by achieving incredible growth in a challenging environment. China’s strategic value to Pfizer is not only in its huge commercial potential, but also as an increasingly important source of innovation in new drug assets and digital / internet-based health care. However, PBG China is facing significant challenges in the next 3-5 years, namely, VBP exposure for its matured products, and relatively lean innovative inline and pipeline portfolio. Business strategy is key to not only overcome the headwinds of VBP but also, more importantly, fully catch the tailwinds and transform the China business to an innovative-focused business and regain the No.1 leadership position in China.
    Role overview
    This China Strategy AD / SM position is a key role reporting to China Strategy Head under China Strategy team. The China Strategy team oversees Pfizer China and BU strategy development, working closely with China Regional President and all BUs / Functions in Pfizer China, as well as with the Pfizer regional /ICO / Global functions. The China Strategy AD/SM will closely work with China Strategy Head to help drive Pfizer China Strategy development and transform Pfizer China to an innovative-focused business through identifying and assessing external and internal key trends, exploring and capturing new opportunities, implementing endorsed strategies, and innovating the commercial model.
    Many of the projects the Strategy team works on are to address ICO leadership team, China President level questions, involving global and local stakeholders across multiple functions. The stakeholders whom this role is managing are senior leaders either from HQ or in China. The strategic projects often have business impact for short term (next 1-2 years) and longer term (next 3-5 years). Besides, this role needs to work closely with China Leadership Team (CLT) to develop BU strategies and drive strategic projects to capture the strategic opportunities that will enable China business to leapfrog and remove hurdles that will hinders success of China business transformation.
    One of the key metrics for evaluating the success of this role and the team is in the endorsement and execution of these strategies and buy-up proposals by global and local cross-functional working teams, by the China leadership team.
    Role key responsibilities
    The China Strategy AD/SM role is pivotal in supporting China Strategy Head to develop top-notch strategies and driving execution excellence – Typical projects are complex and challenging in nature, with high visibility in front of the China and global leadership. They include, but are not limited to, the following:

    Pfizer China Strategy: develop holistic and long-term growth strategies to propel Pfizer China to achieve the growth aspiration and regain the leadership position under the transformational healthcare changes in China

    Portfolio strategy: Develop strategy, direction, and priorities to evolve the current Pfizer China portfolio from a LOE dominated one to an innovative-product-focused one

    BU strategy: Pfizer China has transformed its organization structure and established new franchises (BUs). Work closely with BU GMs/Franchise Heads to define BU growth aspiration, strategy, innovate GTM model unique to each BU’s development stage in China and define growth roadmap for implementation

    Go-to-Market Transformation: The China environment has been evolving quickly in the last few years, with the rising influence of stakeholders beyond HCPs (such as patients, hospital management, medical associations, provincial and city governments, digital healthcare companies etc.). This role also needs to work very closely with Sales, Marketing, Access, Medical, Strategic Innovation to identify and enhance current GTM model, and pilot execution

    Transformation Management Office (TMO): Critical to
    Role expectations
    In order to deliver on the above key responsibilities on a regular basis, the China Strategy AD/SM is expected to meet the following standards and excel in the processes below:

    Strategic thinking mindset, project management and exceptional execution: Under guidance from China Strategy Head, this role will directly manage and execute multiple high-priority projects through opportunity assessment, business valuation, implementation planning. Ensure high deliverable quality, with professionalism, timeliness, and meeting global and local leadership expectations. Continuously engage with senior leaders to align overall direction, outputs, and future implications / next steps

    China leadership team & cross-functional engagement, alignment and resources management: Able to effectively manage communication and build alignment on strategic priorities and implementation. Smoothly navigate cross-function communication, inputs gathering and alignment

    Potential to be seen as a functional expert: This China Strategy AD/SM shall have a good understanding on China healthcare and pharmaceutical macro environment, challenges and opportunities, and able to derive a deeper and robust understanding of critical growth drivers for Pfizer China
    Qualifications

    4-8 years of functional experience in corporate strategy, management consulting, business operations, or strategic marketing related functions

    Relevant healthcare consulting, pharmaceutical / biotech industry experiences, with in-depth knowledge about China pharmaceutical market

    Highly strategic mindset and strong ability to connect the dots

    Outstanding quantitative and analytical skills, including solid analytics, ability to build a compelling story, strategic recommendations, and detailed strategic plans

    Superb ability to engage senior leaders and cross-functional colleagues and build alignment to deliver results in a matrix organization. This includes to advice and influence senior leaders both in China and globally.

    Track record of success and impact in business managed or projects delivered. Must have experience of developing, executing on winning business proposals, with concrete value identified by senior management.

    People management skill & track records of maintaining high-performing team required, either in a solid reporting structure, or in a virtual reporting structure.

    Top-notch skills required – leadership, communication, ability to influence, strategic thinking, project management, problem solving, business acumen, innovativeness and creativity, analytical skills, interpersonal skills, teamwork, risk-taking, and flexibility operating in ambiguous and changing environment.

    Bachelor / Master degree qualification in Strategy, Finance, Marketing or health-related disciplines; MBA-related experience is preferred

    Excellent both English and Mandarin Chinese communications (working professional plus)
    Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
    Bus Dev & Strategic Planning

    工作地點

    北京東城區五礦廣場-B座

    職位發布者

    王先生/區域招聘及入職交付

    當前在線
    立即溝通
    公司Logo輝瑞投資有限公司
    輝瑞公司(Pfizer Inc.)創建于1849年,總部位于美國紐約,是一家以科學為基礎的、創新的、以患者為先的生物制藥公司。輝瑞的使命是“為患者帶來改變其生活的突破創新”。在輝瑞,我們通過科學和全球資源為人們提供治療方案,以延長其生命,顯著改善其生活。在醫療衛生產品的探索、研發和生產過程中,輝瑞始終致力于奉行嚴格的質量、安全和價值標準。我們在全球的產品組合包括創新藥品和疫苗。每天,輝瑞在發達和新興市場的員工都在推進人類健康,推動疾病的預防、治療和治愈,以應對挑戰我們這個時代的頑疾。輝瑞還與醫療衛生服務方、政府和社區合作,支持并促進世界各地的人們能夠獲得更為可靠和可承付的醫療衛生服務。這與輝瑞作為一家全球卓越的創新生物制藥公司的責任是一致的。170余年來,輝瑞一直致力于為所有依賴我們的人帶來改變。輝瑞于1989年進入中國市場。扎根中國30余年,輝瑞已成為在華主要的外資制藥公司之一。2021年是輝瑞新征程的開始。迄今已有170余年歷史的輝瑞正在邁入全新時代,成為一家以科學為基礎的、創新的、以患者為先的生物制藥公司。目前輝瑞在中國業務覆蓋全國300余個城市,累計投資超過15億美元,并設立了1家先進的生產設施,2個研發中心(分別位于上海張江高科技園區和武漢光谷),在華有近7,000名員工分布于業務、研發和生產等領域。輝瑞在華上市了五大領域的高品質創新產品,包括腫瘤、疫苗、抗感染、炎癥與免疫、罕見病等多個領域的處方藥和疫苗,強大完善的產品線旨在滿足生命各階段的健康需求。
    公司主頁
    主站蜘蛛池模板: 亚洲女初尝黑人巨高清| 丰满午夜人妻无码AAAA| 国产黄片在线播放| 亚洲成人资源| 国产精品日韩av在线播放| 毛片在线看免费| 岛国av一区二区精品| 亚州Av无码| 久久精品无码精品免费专区| 精品人妻丰满久久久a| jizzjizzjizzjizz| 人妻av在线| 新版天堂资源中文8在线| 91超碰在线精品| 国产精品A片| av无码天堂| 国内精品久久久久影院优| 无码人妻一区二区三区AV| 亚洲AV无码一区东京热久久| 97精品官网国产户外| 玩弄放荡人妻少妇系列视频| 人妻在线中文字幕| 小泽玛利亚av无码专区| 久久人人爽人人爽人人片av高清| 最新国产精品亚洲| 成人性生交片无码免费看| 免费3?P视频久久| 中文字幕日本人妻| 亚洲成av人片在线观看ww| 日日爽日日操| 陵水| 日本一卡2卡3卡四卡精品网站 | 国产真人性做爰久久网站 | 日韩成人精品中文字幕18禁| 88国产精品视频一区二区三区| 日本视频一两二两三区| 熟女人妻AV| www夜片内射视频日韩精品成人| 欧美成人精品a∨在线观看| 国产亚洲av手机在线观看| 国精产品一区一区三区有限公司杨 |